Xybion Digital Inc.

Equities

XYBN

CA98423T1093

Software

Market Closed - Toronto S.E. 09:48:58 2024-04-29 am EDT 5-day change 1st Jan Change
0.49 CAD +8.89% Intraday chart for Xybion Digital Inc. 0.00% -1.01%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Envol Biomedical selects Xybion?s Preclinical Gold Standard LIMS, Pristima, to Digitize Lab Operations CI
Xybion Digital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Xybion Digital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Xybion Digital Closes Purchase of Autoscribe, US$15 Million Credit Facility MT
Xybion Digital Inc. Announces USD 15 Million Credit Facility CI
Xybion Digital Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Xybion Digital Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Deciphex and Xybion Digital Inc. Join forces to Infuse the Power of Micropathology Digital Slide Reading into Dynamic Non-clinical Study LIMS Workflows CI
Certara, Inc. and Xybion Digital Inc. Partner to Integrate Nonclinical R&D Software to Streamline Assessing Drug Safety & Efficacy CI
Xybion to Streamline, Digitize and Optimize Stability Study Operations and Improve Compliance Using Labwise XD LIMS Platform CI
Xybion Digital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Hubei Topgene Xingsheng Partners with Xybion Digital Inc. to Drive Medical Innovation Using Xybion Preclinical Solution, Pristima Xd CI
Xybion Digital Maintained at Buy as FQ3 Results Come in Weaker than Expected; Price Target Lowered to C$3.15 MT
Xybion Digital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Xybion Digital Announced Proposed Financing of Up to $5 Million MT
Xybion Digital Inc. Receives a Multi-Year, Multi-Million US Dollar Contract CI
Xybion Digital Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Xybion Digital Inc. Enters into an Agreement for A 3-Year, USD 12.2 Million Credit Facility with National Bank of Canada CI
Xybion Digital Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Xybion Digital Inc. Receives 5-Year Multi-Million US Dollar Contract with Leading Global Pharmaceutical Company Headquartered in Europe CI
Xybion Digital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Stira Pharmaceuticals Selects Xybion Digital to Transform Lab Operations CI
Xybion Digital Fiscal Second-Quarter Profit Nearly Triples on Higher Revenue MT
Gravitas One Capital Corp. Reports Earnings Results for the Full Year Ended September 30, 2021 CI
Xybion Corporation completed the acquisition of Gravitas One Capital Corp. (TSXV:GONE.P) in a reverse merger transaction. CI
Chart Xybion Digital Inc.
More charts
Xybion Digital Inc. is a software as a service company, which digitizes drug research and development, laboratory testing, regulatory approvals, and pharmaceutical manufacturing on a cloud platform. It offers solution through Pristima XD, Labwise XD, Xybion QMS, Emidence XD, and ECM XD. Its solutions focus on employee health and safety, integrated preclinical lab management, early-stage drug discovery, digital lab solutions, regulatory compliance, quality management, predictive compliance, content management, and systems validation. The Company help its customers with cloud-enabled Laboratory Information Management System (LIMS) software with embedded document management, data management, compliance, and safety modules. It serves industries, such as life sciences, healthcare and insurance, safety and workers comp, transportation, financial services, food and beverage, manufacturing, petrochemicals, radio pharmacy, biobanking, veterinary sciences, and materials and mining, among others.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. XYBN Stock
  4. News Xybion Digital Inc.
  5. Xybion Digital Maintained at Buy as FQ3 Results Come in Weaker than Expected; Price Target Lowered to C$3.15